Smith Devin Whittemore has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 140000 shares of IO Biotech, Inc. ($IOBT) on April 02, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2025 | IO Biotech, Inc. | $IOBT | Smith Devin Whittemore | General Counsel | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 65,880,914 | 9999.99% | 0.21% |
| Dec. 23, 2024 | IO Biotech, Inc. | $IOBT | Smith Devin Whittemore | General Counsel | P | Common Stock | 12000 | $0.81 | 16,938.0000 | 0 | 243.01% | 0.00% |
| March 15, 2024 | IO Biotech, Inc. | $IOBT | Smith Devin Whittemore | General Counsel | A | Stock Option (Right to Buy) | 185000 | $0.00 | 185,000.0000 | 0 | 9999.99% | 0.00% |